Eli Lilly's Strattera wins FDA approval for maintenance of ADHD - Trading Markets (press release)
|
Eli Lilly's Strattera wins FDA approval for maintenance of ADHD
Trading Markets (press release), CA - May 9, 2008 The safety and efficacy of Strattera in the maintenance of attention-deficit hyperactivity disorder (ADHD) was demonstrated in one of the largest relapse … |
Find Out More:
Books:
- Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
- Attention Deficit Disorder: The Unfocused Mind in Children and Adults
- ADHD Alternatives: A Natural Approach to Treating Attention Deficit Hyperactivity Disorder
- ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
- Ritalin is Not the Answer Action Guide: An Interactive Companion to the Bestselling Drug-Free ADD/ADHD Parenting Program
May 10th, 2008
Strattera
Leave a Reply